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On the occasion of election of Stipan Jonji}
as a member of Leopoldina, the German National
Academy of Sciences
Stipan Jonji} and his group havebeen investigating the immune
control of cytomegalovirus (CMV)
infection for over 25 years. The
major scientific achievement of his
group is the characterization of se-
veral mechanisms involved in im-
munosurveillance of acute and la-
tent murine CMV (MCMV) infec-
tion. Working in close collaboration
with Professor Ulrich Koszinow-
ski (Germany) his group was the
first to show that CD4 T cells are
essential for control of horizontal virus spread and can compensate the
function of CD8 T cells when these cells are depleted. His group
provided the first evidence that immunosurveillance of latent CMV
infection is organized in a hierarchical and redundant fashion, with not
only CD8 T cells but also CD4 T cells and NK cells playing an
important role. The group pioneered the work on MCMV evasion of
NK cells and characterized several viral proteins involved in down-
modulation of NKG2D ligands. More recently, they established the
MCMV model of congenital CMV infection of CNS and demonstrated
impaired development of cerebellum of infected animals coupled with
inflammatory lesions. They have also made a significant contribution to
elucidating the recognition of MCMV infected cells by Ly49 NK cell
receptors and molecular mechanism involved in specific recognition of
infected cells by several activating Ly49 receptors. The group has been
the first to show that 'missing-self ' dependent NK cell activation plays a
role in virus control and characterized viral immunoevasion of this
effector mechanism.
Stipan Jonji} has published over 100 papers, mostly in the field of
virology and immunology and has been invited lecturer to prestigious
international conferences and universities. He has worked as a princi-
pal investigator on several national and international scientific projects,
including those funded by the European Commission and US Natio-
nal Institutes of Health. His scientific work has been characterized by a
long and intense international cooperation. For his scientific achieve-
ments he was awarded several national and international prizes. He has
been principal advisor to 15 PhD students. Two of his PhD students
were awarded the Humboldt fellowship, two of them received the
ANI GERBIN
University of Rijeka
Faculty of Medicine Center for Proteomics
B. Branchetta 20, 51000 Rijeka, Croatia
E-mail: agerbin@medri.hr
Received September 11, 2012.
PERIODICUM BIOLOGORUM UDC 57:61
VOL. 114, No 2, 235–236, 2012 CODEN PDBIAD
ISSN 0031-5362
News
EMBO fellowship, one was awarded HHMI fellowship
and one was awarded the ERC Starting Grant.
The appointment of Stipan Jonji} as a member of
Leopoldina is a remarkable recognition to his scientific
achievements in the field of viral immunology. Founded
almost 350 years ago, Leopoldina is the oldest academy
for medicine and natural sciences in the world. It was
appointed the German National Academy of Sciences in
2008. It acts as an independent adviser of public insti-
tutions and bodies on scientific issues and encourages
the exchange of ideas with foreign researchers and or-
ganisations. Approximately three quarters of its members
are from German-speaking countries and one quarter
from 30 other nations.
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